论文信息 - CML-047 Post Hoc Analysis of Responses to Ponatinib in Patients With Chronic-Phase Chronic Myeloid Leukemia (CP-CML) by Baseline BCR::ABL1 Level and Baseline Mutation Status in the OPTIC Trial. - 字舞流文

CML-047 Post Hoc Analysis of Responses to Ponatinib in Patients With Chronic-Phase Chronic Myeloid Leukemia (CP-CML) by Baseline BCR::ABL1 Level and Baseline Mutation Status in the OPTIC Trial.

G. Rosti | J. Cortes | M. Deininger | C. Chuah | J. Lipton | M. Mauro | P. Rousselot | A. Hochhaus | J. Apperley | H. de Lavallade | L. Maness | C. Arthur | E. Lomaia | C. Pavlovsky | J. Mccloskey | A. Vorog | Xi-Ling Ren | Beatriz Moraghi | M. U. Sutton | X. Ren